Bixiye
P41-21 eviCore Healthcare Specialty Utilization Management (UM) Program Radiation Oncology Clinical Guideline Updates for Fully Insured Commercial and Medicare Advantage Subscribers
Taariikhda dhaqangalka Barnaamijka: Jul 01, 2021
Natiijooyinka Raadinta
Soo bandhiga 2141 - 2150 ee natiijooyinka 3690
Bixiye
Substrate Reduction Therapy - Commercial
Prior Authorization, Quantity Limit
Taariikhda wax ku ool ah ee barnaamijka: Jun 01, 2025
Bixiye
QP52-21 Commercial and MHCP Pharmacy Benefit Exclusion for AduhelmTM
Taariikhda wax ku ool ah ee barnaamijka: Jun 23, 2021
Bixiye
QP53-21 Medical Drug Exclusion List Update – for Euflexxa
Taariikhda wax ku ool ah ee barnaamijka: Jun 23, 2021
Bixiye
2021 July Bulletins
Taariikhda dhaqangalka Barnaamijka: Jul 01, 2021
Bixiye
Zokinvy (lonafarnib) - Commercial
Prior Authorization, Quantity Limit
Taariikhda wax ku ool ah ee barnaamijka: Jun 01, 2025
Bixiye
Imcivree™ (setmelanotide) - Commercial
Prior Authorization, Quantity Limit
Taariikhda barnaamijka Dhaqangalayso Agosto 01, 2024
Bixiye
Substrate Reduction Therapy - Medicaid
Prior Authorization, Quantity Limit
Taariikhda wax ku ool ah ee barnaamijka: Jun 01, 2025
Bixiye
P7R1-21 Update: Change in Liability for Members of Other Blue Plans
Taariikhda dhaqangalka Barnaamijka: Jul 01, 2021